Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Role of a muscle factor in the development of low back pain

https://doi.org/10.14412/2074-2711-2017-2-95-101

Full Text:

Abstract

Myofascial pain syndrome (MFPS) is a chronic pain syndrome characterized by the formation of myofascial trigger points (MTP). MFPS most frequently occurs in patients with neck pain. The peripheral and central aspects of the formation of MTP, MFPS diagnostic criteria, piriformis syndrome, fibromyalgia, the impact of MFPS on quality of life and functional activity in patients are discussed.

MFPS is treated according to the international guidelines for the treatment of nonspecific spinal pain, which encompass patient education programs, therapeutic exercises, early mobilization, manual therapy techniques, and nonsteroidal anti-inflammatory drugs as first-line analgesic agents. Meloxicam is noted to be highly effective in treating low back pain, including myofascial pain.

The application of a low back muscular corset and its ability to protect vertebral structures from damage are considered. At present, there is no evidence for a link between the status of spinal muscles (according to magnetic resonance imaging and computed tomography) and the intensity of pain syndrome and the degree of disability.

About the Authors

A. I. Isaikin
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation

Department of Nervous System Diseases and Neurosurgery

11, Rossolimo St., Moscow 119021 



G. E. Shevtsova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation

Department of Nervous System Diseases and Neurosurgery

11, Rossolimo St., Moscow 119021 



D. O. Rozhkov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation

Department of Nervous System Diseases and Neurosurgery

11, Rossolimo St., Moscow 119021 



A. V. Kavelina
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation

Department of Nervous System Diseases and Neurosurgery

11, Rossolimo St., Moscow 119021 



M. A. Ivanova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation

Department of Nervous System Diseases and Neurosurgery

11, Rossolimo St., Moscow 119021 



References

1. Shah JP, Thaker N, Heimur J. Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective. PM R. 2015 Jul;7(7): 746-61. doi: 10.1016/j.pmrj.2015.01.024. Epub 2015 Feb 24

2. Подчуфарова ЕВ, Яхно НН. Боль в спине. Москва: ГЭОТАР-Медиа; 2014. С. 94-118. [Podchufarova EV, Yakhno NN. Bol' v spine [Back pain]. Moscow: GEOTAR-Media; 2014. P. 94-118.]

3. Treaster D, Marras WS, Burr D, et al. Myofascial trigger point development from visu￾al and postural stressors during computer work. J Electromyogr Kinesiol. 2006 Apr;16(2):115-24. Epub 2005 Sep 16.

4. Hagg GM. Static workload and occupational myalgia-a new explanation model. In: Anderson P, Hobard D, Danoff J, editors. Electromyographical Kinesiology. Amsterdam: Elsevier; 1991. P. 141-4.

5. Shah JP, Gilliams EA. Uncovering the bio￾chemical milieu of myofascial trigger points using in vivo microdialysis: An application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther. 2008 Oct;12(4): 371-84. doi: 10.1016/j.jbmt.2008.06.006. Epub 2008 Aug 13.

6. Stecco C, Stern R, Porzionato A, et al. Hyaluronan within fascia in the etiology of myofascial pain. Surg Radiol Anat. 2011 Dec;33(10):891-6. doi: 10.1007/s00276-011- 0876-9. Epub 2011 Oct 2.

7. Dommerholt J, Huijbregts P. Myofascial Trigger Points: Pathophysiology and Evidence￾Informed Diagnosis and Management. Sudbury: Jones and Bartlett; 2011.

8. Quintner J, Cohen M. Referred pain of peripheral nerve origin: Analternative to the 'myofascial pain' construct. Clin J Pain. 1994 Sep;10(3):243-51.

9. Butler D. The Sensitive Nervous System. Adelaide: Noigroup Publications; 2006. 430 p.

10. Lluch E, Nijs J, De Kooning M, Van Dyck D. Prevalence, Incidence, Localization, and Pathophysiology of Myofascial Trigger Points in Patients With Spinal Pain: A Systematic Literature Review. J Manipulative Physiol Ther. 2015 Oct; 38(8):587-600. doi: 10.1016/j.jmpt.2015.08.004.

11. IASP. Myofascial pain. 2017. http://www.iasp ain.org/files / Musculo skeletal Pain Fact Sheets14 /Myofascial Pain_Final.

12. Chiarotto A, Clijsen R, Fernandez-de-Las-Penas C. Prevalence of Myofascial Trigger Points in Spinal Disorders: A Systematic Review and Meta-Analysis. Arch Phys Med Rehabil. 2016 Feb;97(2):316-37. doi: 10.1016/ j.apmr.2015.09.021

13. Jankovic D, Peng P, van Zundert A. Brief review: piriformis syndrome: etiology, diagnosis, and management. Can J Anaesth. 2013 Oct; 60(10):1003-12. doi: 10.1007/s12630-013-0009-5. Epub 2013 Jul 27.

14. Papadopoulos EC, Khan SN. Piriformis syndrome and low back pain: a new classifica￾tion and review of the literature. Orthop Clin North Am. 2004 Jan;35(1):65-71.

15. Wolfe F, Smithe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72.

16. Табеева ГР. Фибромиалгия: формирование симптомов и принципы терапии. Неврология, нейропсихиатрия, психосоматика. 2012;4(1):23-7. [Tabeeva GR. Fibromyalgia: development of symptoms and principles of therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;4(1):23-7. (In Russ.)]. doi: 10.14412/2074-2711-2012-357

17. Vining R, Potocki E, Seidman M, Morgenthal AP. An evidence-based diagnostic classification system for low back pain. J Can Chiropr Assoc. 2013 Sep;57(3):189-204.

18. Petersen T, Laslett M. Clinical classification in low back pain: best-evidence diagnostic rules based on systematic reviews. BMC Musculoskelet Disord. 2017 May 12;18(1):188. doi: 10.1186/ s12891-017-1549-6

19. Turo D, Otto P, Shah JP, et al. Ultrasonic characterization of the upper trapezius muscle in patients with chronic neck pain. Ultrason Imaging. 2013 Apr;35(2):173-87. doi: 10.1177/ 0161734612472408.

20. Sikdar S, Ortiz R, Gebreab T, et al. Understanding the vascular environment of myofascial trigger points usingultrasonic imaging and computational modeling. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2010. P. 5302-5.

21. Dommerholt J, Shah JP, Ballantyne JC. Myofascial Pain Syndrome. 4th edition. Baltimore: Williams & Wilkins; 2010.

22. Парфенов ВА, Исайкин АИ. Боль в нижней части спины: мифы и реальность. Москва: ИМА-ПРЕСС; 2016. C. 84-9. [Parfenov VA, Isaikin AI. Bol' v nizhnei chasti spiny: mify i real'nost' [Loe back pain: myths and reality]. Moscow: IMA-PRESS; 2016. P. 84-9.]

23. Low Back Pain and Sciatica in Over 16s: Assessment and Management. London: National Institute for Health and Care Excellence (UK); 2016.

24. Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017 Apr 4; 166(7):514-530. doi: 10.7326/M16-2367. Epub 2017 Feb 14.

25. Wong JJ, Cote P, Sutton DA, et al. Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J Pain. 2017 Feb;21(2):201-216. doi: 10.1002/ejp. 931. Epub 2016 Oct 6.

26. Enthoven WT, Roelofs PD, Deyo RA, et al. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016 Feb 10;2:CD012087. doi: 10.1002/ 14651858.CD012087

27. Парфенов ВА, Герасимова ОН. Клинический опыт применения мелоксикама (Мовалис®) при неспецифической боли в спине и радикулопатии. Неврология, нейропсихиатрия, психосоматика. 2012;4(2): 68-72. [Parfenov VA, Gerasimova ON Clinical experience with meloxicam (Movalis®) in nonspecific back pain and radiculopathy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;4(2):68-72. (In Russ.)]. doi: 10.14412/ 2074-2711-2012-387

28. Новикова ЛБ, Акопян АП. Миофасци- альный болевой синдром. Лечащий врач. 2016;(4):16-20. [Novikova LB, Akopyan AP. Myofascial pain syndrome. Lechashchii vrach. 2016;(4):16-20. (In Russ.)].

29. Шостак НА, Клименко АА. Болевой синдром в спине: современные подходы к терапии. Клиницист. 2015;(2):36-40. [Shostak NA, Klimenko AA. Back pain: current approaches to therapy. Klinitsist. 2015;(2):36-40. (In Russ.)].

30. Van Hecken A, Schwartz JI, Deprе M, et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naprox￾en on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol. 2000 Oct;40(10):1109-20.

31. Ding C. Do NSAIDs affect the progression of osteoarthritis? Inflammation. 2002 Jun;26(3):139-42.

32. Xu S, Rouzer CA, Marnett LJ. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. IUBMB Life. 2014 Dec;66(12): 803-11. doi: 10.1002/iub.1334. Epub 2014 Dec 23.

33. Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Med Clin North Am. 2007 Mar;91(2):229-39.

34. Soares A, Andriolo RB, Atallah AN, da Silva EM. Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD007533. doi: 10.1002/14651858.CD007533

35. Cagnie B, Castelein B, Pollie F. Evidence for the Use of Ischemic Compression and Dry Needling in the Management of Trigger Points of the Upper Trapezius in Patients with Neck Pain: A Systematic Review. Am J Phys Med Rehabil. 2015 Jul;94(7):573-83. doi: 10.1097/PHM.0000000000000266

36. Paalanne N, Niinimä ki J, Karppinen J. Assessment of association between low back pain and paraspinal muscle atrophy using opposed-phase magnetic resonance imaging: a population-based study among young adults. Spine (Phila Pa 1976). 2011 Nov 1;36(23):1961-8. doi: 10.1097/BRS.0b013e3181fef890.

37. Cagnie B, Dhooge F, Schumacher C. Fiber Typing of the Erector Spinae and Multifidus Muscles in Healthy Controls and Back Pain Patients: A Systematic Literature Review. J Manipulative Physiol Ther. 2015 Nov-Dec; 38(9):653-63. doi: 10.1016/j.jmpt.2015.

38. Suri P, Fry AL, Gellhorn AC. Do Muscle Characteristics on Lumbar Spine Magnetic Resonance Imaging or Computed Tomography Predict Future Low Back Pain, Physical Function, or Performance? A Systematic Review. PM R. 2015 Dec;7(12):1269-81. doi: 10.1016/j.pmrj.2015.04.016

39. Goubert D, Oosterwijck JV, Meeus M. Structural Changes of Lumbar Muscles in Non￾specific Low Back Pain: A Systematic Review. Pain Physician. 2016 Sep-Oct;19(7): E985-E1000.

40. Bhadresha A, Lawrence O , McCarthy MA. Comparison of Magnetic Resonance Imaging Muscle Fat Content in the Lumbar Paraspinal Muscles with Patient-Reported Outcome Measures in Patients with Lumbar Degenerative Disk Disease and Focal Disk Prolapse. Global Spine J. 2016 Jun;6(4):401-10. doi: 10.1055/s- 0036-1583290. Epub 2016 Apr 28

41. Goubert D, De Pauw R, Meeus M. Lumbar muscle structure and function in chronic versus recurrent low back pain: a cross-sectional study. Spine J. 2017 Apr 26. pii: S1529- 9430(17)30182-1. doi: 10.1016/j.spinee.2017.04.025. [Epub ahead of print]

42. Geneen LJ, Moore RA, Clarke C. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017 Apr 24;4:CD011279. doi: 10.1002/14651858

43. IASP. Myofascial pain. 2017. http://www. iasp ain.org/files/FACT SHEET No. 8 Exercise in Management of Musculoskeletal Pain_Final.


For citation:


Isaikin A.I., Shevtsova G.E., Rozhkov D.O., Kavelina A.V., Ivanova M.A. Role of a muscle factor in the development of low back pain. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(2):95-101. (In Russ.) https://doi.org/10.14412/2074-2711-2017-2-95-101

Views: 268


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)